FDA approves two-hour blood test for staph
Contemporary Long-Term Care Weekly, January 10, 2008
BD Diagnostics has announced that it received clearance from the U.S. Food and Drug Administration for a test to quickly identify the presence of two deadly infections often associated with healthcare facilities-Staphylococcus aureus and methicillin-resistant Staphylococcus aureus (MRSA)-from positive blood cultures.
The company said the tests provide results within two hours, are easy to perform, and require less technologist time than traditional microbiology algorithms, which can take two days.
The rapid tests will allow for more appropriate isolation procedures and agent-specific antimicrobial therapy, ultimately reducing mortality, length of stay, and healthcare costs, according to the company.
Comments
0 comments on “FDA approves two-hour blood test for staph ”
Related Products
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- QA:Coding multiple initial infusions
- Capturing all necessary codes for IUD insertion and removal can be challenging
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- OB services: Coding inside and outside of the package
- HIPAA Q&A: Level of encryption needed for email
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Hospitalist-surgeon comanagement has no effect on outcomes
- HIPAA Q&A: Level of encryption needed for email
- Case Management Monthly, June 2012
- Searched
